EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H17N3O2 |
| Net Charge | 0 |
| Average Mass | 295.342 |
| Monoisotopic Mass | 295.13208 |
| SMILES | CN(C)CC(=O)Nc1ccc2nc(=O)c3ccccc3c2c1 |
| InChI | InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22) |
| InChIKey | UYJZZVDLGDDTCL-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30). apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. |
| Applications: | neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. cardioprotective agent Any protective agent that is able to prevent damage to the heart. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. anti-inflammatory agent Any compound that has anti-inflammatory effects. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| PJ34 (CHEBI:167900) has role angiogenesis inhibitor (CHEBI:48422) |
| PJ34 (CHEBI:167900) has role anti-inflammatory agent (CHEBI:67079) |
| PJ34 (CHEBI:167900) has role antiatherosclerotic agent (CHEBI:145947) |
| PJ34 (CHEBI:167900) has role antineoplastic agent (CHEBI:35610) |
| PJ34 (CHEBI:167900) has role apoptosis inducer (CHEBI:68495) |
| PJ34 (CHEBI:167900) has role cardioprotective agent (CHEBI:77307) |
| PJ34 (CHEBI:167900) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| PJ34 (CHEBI:167900) has role neuroprotective agent (CHEBI:63726) |
| PJ34 (CHEBI:167900) is a phenanthridines (CHEBI:51245) |
| PJ34 (CHEBI:167900) is a secondary carboxamide (CHEBI:140325) |
| PJ34 (CHEBI:167900) is a tertiary amino compound (CHEBI:50996) |
| PJ34 (CHEBI:167900) is conjugate base of PJ34(1+) (CHEBI:167903) |
| Incoming Relation(s) |
| PJ34(1+) (CHEBI:167903) is conjugate acid of PJ34 (CHEBI:167900) |
| IUPAC Name |
|---|
| 2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide |
| Synonyms | Source |
|---|---|
| 2-(dimethylaminoacetylamino)-5,6-dihydrophenanthridine-6-one | ChEBI |
| 2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide | ChEBI |
| N-(5,6-dihydro-6-oxo-2-phenanthridinyl)-2-(dimethylamino)acetamide | ChEBI |
| N-(5,6-dihydro-6-oxophenanthridine-2-yl)-2-(dimethylamino)acetamide | ChEBI |
| N2,N2-dimethyl-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)glycinamide | IUPAC |
| PJ 34 | ChEBI |
| Citations |
|---|